These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32842424)

  • 1. [Imaging modalities in the assessment of presacral recurrent rectal cancer].
    Wang Y; Yang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):456-460. PubMed ID: 32842424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beware of False-Positive FDG PET/CT Interpretations for Presacral Recurrent Rectal Cancer.
    Pennings JP; de Haas RJ; de Jong KP; Dierckx RAJO; Kwee TC
    Clin Nucl Med; 2019 May; 44(5):e342-e344. PubMed ID: 30888991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidance of magnetic resonance imaging for target area delineation of postoperative presacral recurrence of rectal cancer].
    Li XN; Liu T; Wang C; Guo P; Ye YJ; Chen YL; Cheng J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1170-1176. PubMed ID: 33353272
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer.
    Fukunaga H; Sekimoto M; Tatsumi M; Ikenaga M; Ohue M; Seshimo I; Higuchi I; Takayama O; Yasui M; Ikeda M; Yamamoto H; Monden M
    Int J Oncol; 2002 Apr; 20(4):691-5. PubMed ID: 11894111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
    Katsumoto Y; Maruyama N; Nakamura M; Shingai T; Maruyama K; Nakaguchi K; Furukawa J; Okajima S; Sue F; Fukunaga H; Ikenaga M; Sekimoto K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1688-91. PubMed ID: 11708010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
    Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.
    Shao H; Ma X; Gao Y; Wang J; Wu J; Wang B; Li J; Tian J
    Medicine (Baltimore); 2018 Nov; 97(48):e12900. PubMed ID: 30508883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
    Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
    Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
    Bellomi M; Rizzo S; Travaini LL; Bazzi L; Trifirò G; Zampino MG; Radice D; Paganelli G
    Radiol Med; 2007 Aug; 112(5):681-90. PubMed ID: 17657420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
    Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C
    Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.
    Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U
    Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
    Chessin DB; Kiran RP; Akhurst T; Guillem JG
    J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700
    [No Abstract]   [Full Text] [Related]  

  • 18. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
    Staib L; Schirrmeister H; Reske SN; Beger HG
    Am J Surg; 2000 Jul; 180(1):1-5. PubMed ID: 11036130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Plodeck V; Platzek I; Streitzig J; Nebelung H; Blum S; Kühn JP; Hoffmann RT; Laniado M; Michler E; Hoberück S; Zöphel K; Kotzerke J; Fritzmann J; Weitz J; Radosa CG
    Abdom Radiol (NY); 2021 Nov; 46(11):5086-5094. PubMed ID: 34402948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.